Latest Breaking News On - Mcgill centre for translational research in cancer - Page 1 : comparemela.com

Alpha Tau (DRTS) Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

Alpha Tau (DRTS) Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Corey millerAlpha daAlpha tau medical ltdTherapeutic endoscopy of the division gastroenterologyLady davis instituteMcgill universityProfessor of medicine at mcgill universityInstitute transmedtechMcgill centre for translational research in cancerAlpha tau medicalSerious adverse eventsJewish general hospitalPancreatic cancer awarenessTherapeutic endoscopyAssistant professorAssociate researcher

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received.

Israel generalUnited statesAlpha daCorey millerYona keisariItzhak kelsonProfessor of medicine at mcgill universityMcgill universityInstitute transmedtechMcgill centre for translational research in cancerTel aviv universityExchange commissionAlpha tau medical ltdTherapeutic endoscopy of the division gastroenterologyLady davis instituteSerious adverse events

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -

Israel generalUnited statesAlpha daItzhak kelsonYona keisariCorey millerInstitute transmedtechTherapeutic endoscopy of the division gastroenterologyExchange commissionLady davis instituteMcgill universityAlpha tau medical ltdTel aviv universityProfessor of medicine at mcgill universityMcgill centre for translational research in cancerSerious adverse events

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,. | April 3, 2023

Israel generalMarie pierreYona keisariAlpha daDiane cotePascal fischerMiriam santos dutraPolytechnique montrItzhak kelsonCorey millerAlpha tau medical ltdMcgill universityProfessor of medicine at mcgill universityCentre for clinical epidemiologyCanadian consortium for industrial researchMcgill centre for translational research in cancer

Alpha Tau and the JGH Announce Alpha DaRT Treatment of

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable.

United statesIsrael generalPolytechnique montrItzhak kelsonCorey millerAlpha daDiane cotePascal fischerYona keisariMiriam santos dutraInnovation in medical technologyCentre for nursing researchMcgill centre for translational research in cancerTransmedtech instituteTherapeutic endoscopy of the division gastroenterologyTerry fox molecular oncology group